TCT-12 Results From the CAMI1 Study: Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction
Journal of the American College of Cardiology(2019)
摘要
Inflammation is increasingly recognized as an important pathogenic feature in cardiovascular disease. In patients with ST-segment elevation myocardial infarction (STEMI), C-reactive protein (CRP), the prototype human acute phase protein, is a marker of poor prognosis and independently predicts 30-
更多查看译文
关键词
selective crp apheresis,myocardial infarction,acute myocardial infarction,cami1 study
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要